Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study:Clinical Trial on the Tacrolimus Dosage Range in Chinese Renal Transplant Recipients With Different Genetic Phenotypes of Drug Metabolizing Enzymes(CYP3A5)

NCT00935298 is registered in ClinicalTrials.gov with The Second Artillery General Hospital as lead sponsor.

NCT NCT00935298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00935298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study:Clinical Trial on the Tacrolimus Dosage Range in Chinese Renal Transplant Recipients With Different Genetic Phenotypes of Drug Metabolizing Enzymes(CYP3A5)
Lead sponsor
The Second Artillery General Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
June 30, 2011
Enrollment
145 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation